Anders Månsson Email & Phone Number

Malmö, SE

Lund, Skåne County, Sweden

PHI (Phase Holographic Imaging) is a development company in digital microscopy/cytometry. The company’s HoloMonitor® live cell imaging system supports the development of cell therapy by allowing individual cells to be non-invasively visualized with holography and quantified over time on a population level inside a cell incubator. The system relies on AI.

Malmö, Skåne County, Sweden

Immetric is a Europe focused seed capital investment fund that can add top notch IP verification and advice, as well as start-up savviness, on top of the investment capital that it provides for early stage innovation in tech and life sciences.

Lund, Sweden

EQL Pharma is a listed niche generics- and speciality pharma company, dedicated to providing cost effective pharmaceuticals for the European markets.

Oslo, Norway

Based in Oslo, Norway, Oncoinvent has some 50 employees. It is privately held and backed by VC. The company has thus far demonstrated excellent clinical results with its key radio-pharmaceutical product candidate, Radspherin®, for Peritoneal Carcinomatosis (PC). The goal is to continue this development journey, and ultimately establish a new standard.

Sweden

LIDDS is a technology platform company specialising in depot formulations for intra-tumoral injections with its NanoZolid technology. This allows for effective dose delivery while minimising systemic side effects, an important feature in oncology. LIDDS focuses on early-stage partnership with pharmaceutical companies, for new and established APIs, and.

Lund, Sweden

RhoVac AB was a Swedish publicly listed bio-pharmaceutical company dedicated to drug development in the oncology area. RhoVac merged with Chosa in 2022.

Lund, Sweden

Amniotics AB is a stem cell research based company backed by, among others, venture capitalist and renowned serial entrepreneur Christer Fåhraeus. The mission of the company is to produce, with amniotic fluid as the source, cutting edge stem cell therapy for the benefit of patients around the world.

Lund, Sweden

My main role as CEO was first and foremost to turn the company’s discoveries, inventions and patents into value generating and workable business models. As CEO, I took the company to its first external funding round.

Lund, Sweden

Malmo, Sweden

CanImGuide Therapeutics AB was founded in 2006 in order to further develop new treatments, primarily for cancer, by targeting peptide sequences related to immunosuppression. I left the CIG Board when I joined RhoVac on the basis of "non-compete".

Stockholm, Sweden

Ratos AB is a listed Swedish Private Equity Company with a Market Cap in excess of 1 Billion USD, and I acted as an Industrial Advisor for them in the area of Life Sciences.

Lund, Sweden

Respiratorius AB is company that develops new and effective candidate drugs for treatment of cancer, COPD and asthma. Respiratorius (RESP) is listed at the Equities Market Place ("Spotlight Stock Market") since 2012. I left the Respiratorius Board when I joined RhoVac on the basis of "non-compete".

Copenhagen Area, Denmark

Heading global brand management, commercial insights, market access, pricing and scientific affairs (the latter through dotted line) for the Group’s portfolios in Psoriasis, Skin Cancer and OTC/Consumer. These portfolios are the mainstay of LEO and the annual turnover of the strategic brands in these categories is ca. ½ Billion EUR. My team of ca. 30 heads.

Copenhagen Area, Denmark

Heading the Global Business Development function (Acquisition Strategy, Partnerships and M&A execution) for the LEO Group. In essence responsible for leading the development and implementation of strategies for inorganic growth, including transaction execution. Member of the LEO Global Management Team (GMT). In my time at the helm of Global Business.

Copenhagen, Denmark

Global P&L responsibility, and cross functional leadership (sales, marketing, finance, regulatory & supply), for LEO Pharma's corporate established products division. Turnover ca. 150 Million EUR. Ca. 70 solid line reports. Member of the Global Sales & Marketing Management Team as well as of the cross functional LEO Top Leadership Team (LTLT). The unit.

Copenhagen, Denmark

General Manager with full P&L responsibility, and cross functional leadership (sales, marketing, finance, regulatory & medical), for Ferring's Danish S&M Affiliate. Turnover ca. 15 Million EUR.

St Prex, VD, Switzerland

Re-building in the new HQ in Switzerland, and heading a corporate function with an integrated responsibility for Corporate Strategic Planning, Business Intelligence, Pricing & Market Access. The unit did BD acquisition target evaluation, R&D pipeline evaluation as well as managing business analytics, pricing and intelligence at the corporate level.

Copenhagen, Denmark

Starting and heading a corporate function with an integrated responsibility for Corporate Strategic Planning, Business Intelligence, Pricing & Market Access. The unit did BD acquisition target evaluation, R&D pipeline evaluation as well as managing business analytics, pricing and intelligence at the corporate level.

Copenhagen, Denmark / London, UK

Planning and executing business affiliate reviews/audits, first with a European scope, then with a global one. Project management spanning S&M and Supply Chain functions.

Malmö, Sweden

Starting & heading a national Ob/Gyn Business Unit and also heading national Key Account & Tender Management across therapy areas

Malmö, Sweden

Product Management, Urology, first on a national (Swedish) basis, then on a regional (Nordic) basis

Malmö, Sweden

Managing District Sales, Urology

Malmö, Sweden

Managing District Sales, Rx